Protection Against Chickenpox: A Chinese Vaccine Is Now Available in Kazakhstan!
Many of us remember having chickenpox as children, but it is not as harmless as it may seem.
Chickenpox is generally considered a harmless childhood infection. Parents sometimes even deliberately want their children to catch chickenpox at an early age. In most cases, the infection is indeed mild, causing fever, general discomfort, and a blister-like rash filled with fluid.
However, the disease can be severe in some people. Numerous lesions may appear not only on the skin but also inside the mouth, where they can be painful and lead to refusal to eat or drink and subsequent dehydration. The gastrointestinal tract may also be affected, causing abdominal pain and diarrhea, as can the respiratory tract, potentially resulting in viral pneumonia.
The lesions may become infected and require antibiotic treatment, leaving significant skin damage and scars. Later in life, the varicella-zoster virus may reactivate in someone who has had chickenpox and cause shingles.
For all these reasons, vaccinating children against chickenpox at 12 months of age has become standard practice worldwide. We are pleased to announce that a batch of chickenpox vaccine manufactured in China has arrived in Kazakhstan.
Who Is Vaccination Recommended For?
Progressive or uncontrolled neurological disorders, including encephalopathy and epilepsy
Immunodeficiency, a weakened immune system, or ongoing immunosuppressive therapy
An allergic reaction to any vaccine component, including excipients
Acute illnesses or chronic illnesses during an exacerbation
Children aged 12 months and older
People who have not previously had chickenpox